Genet Med. 2001 Jan-Feb;3(1):79-84.

Neuropsychiatric disorders in the 22q11 deletion syndrome.

Niklasson L, Rasmussen P, Oskarsdottir S, Gillberg C.

Department of Child and Adolescent Psychiatry, University of Goteborg, Queen Silvia Children's Hospital, Sweden.

 

PURPOSE: This study was undertaken with a view to establishing the occurrence of neuropsychiatric disorders in the 22q11 deletion syndrome. METHODS: Thirty-two children and young adults with genetically confirmed 22q11 deletion were given comprehensive neuropsychiatric assessments. RESULTS: Altogether, 56% had a neuropsychiatric disorder. Only 6% were of normal IQ and free of physchiatric disorder. Attention-deficit/hyperactivity disorder was diagnosed in 44% and 31% had an autism spectrum problem. In 16% criteria for both these diagnoses were met. Fifty-three percent had mental retardation, often with a test-profile suggesting a nonverbal learning disorder. CONCLUSION: The findings imply that a majority of children and adolescents with 22q11 deletion syndrome are in need of neuropsychiatric assessment and intervention.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=Abstract&list_uids=11339385&query_hl=1&itool=pubmed_DocSum